Systemic osteoarthritis: the difficulty of categorically naming a continuous condition
Aging Clinical and Experimental Research · 2024
DOI: 10.1007/s40520-024-02714-w ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Aging Clinical and Experimental Research, 2024. Verfasst von Gabriel Herrero-Beaumont und 5 weiteren Autor:innen. Beteiligte Einrichtung: Bone and Joint Research Unit, Rheumatology Dept, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain. gherrero@fjd.es. Hauptthemen laut MEDLINE: Quality of Life, Osteoarthritis. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Osteoarthritis (OA) is a disease with systemic implications that go beyond joint problems. Its pathogenic mechanisms involve a variety of systemic conditions that contribute to joint damage. These include metabolic dysfunction, chronic low-grade inflammation, neuroplastic pain, and the influence of the central nervous system in the development of neuropathic pain. Besides, OA can negatively affect other aspects of health, such as quality of life, reduced physical activity, social isolation, depression, and anxiety. OA can be considered a complex system in which pathological interactions involve not only obesity and metabolic dysfunction, but also fragility syndrome, sarcopenia, neurological complications, and systemic energy redistribution. Complex systems are composed of multiple interacting and dynamic parts and exhibit emergent properties that cannot be fully explained by examining their individual components. Chronic low-grade inflammation is characteristic of OA, occurring both in the affected joint, and systemically, mainly due to adipose tissue inflammation in obese patients. Obesity is a key factor in the progression of OA, so primary treatment should focus on its control, while maintaining muscle health. The chronic inflammation could lead to changes in energy distribution among the affected joint tissues. Therefore, OA should be approached as a systemic disease, considering individual patient factors, such as genetics, inflammatory response, and lifestyle. Medical care should be more holistic and personalized. Consideration of a name change, such as "systemic OA", could help to move away from the perception of a disease focused only on the joints.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Bone and Joint Research Unit, Rheumatology Dept, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain. gherrero@fjd.es.
- Rheumatology Department, Teknon Medical Center, Quironsalud Group, Barcelona, Spain.
- Rheumatology Unit, San Pietro Fatebenefratelli Hospital, Rome, Italy.
- Bone and Joint Research Unit, Rheumatology Dept, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain.
- WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging, Division of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.
Zitieren
APA
Herrero-Beaumont, G., Castro-Dominguez, F., Migliore, A., Naredo, E., Largo, R., & Reginster, J. Y. (2024). Systemic osteoarthritis: the difficulty of categorically naming a continuous condition. Aging Clinical and Experimental Research. https://doi.org/10.1007/s40520-024-02714-w
Vancouver
Herrero-Beaumont G, Castro-Dominguez F, Migliore A, Naredo E, Largo R, Reginster JY. Systemic osteoarthritis: the difficulty of categorically naming a continuous condition. Aging Clinical and Experimental Research. 2024. doi:10.1007/s40520-024-02714-w
BibTeX
@article{HerreroBeaumont2024,
author = {Herrero-Beaumont, Gabriel and Castro-Dominguez, Francisco and Migliore, Alberto and Naredo, Esperanza and Largo, Raquel and Reginster, Jean-Yves},
title = {Systemic osteoarthritis: the difficulty of categorically naming a continuous condition},
journal = {Aging Clinical and Experimental Research},
year = {2024},
doi = {10.1007/s40520-024-02714-w}
}
EUVIMED